About
The Board
About the Board
Board Members
Committees
Contact Us
For The
Public
For The Public
Find a Registered Pharmacy Professional or Licensed Pharmacy
Newfoundland and Labrador Pharmacy Museum
Complaints
& Discipline
Complaints & Discipline Overview
Hearing Details
Adjudication Tribunal Decisions
Registration
& Licensing
Registration Requirements
Registration Exam
Register as a Pharmacist
Register as a Pharmacy Technician
Register as a Pharmacy Student or Intern
Annual Registration Renewal
Leave and Re-registration
Authorization for Registrants
License a Pharmacy
Authorization for Pharmacies
Fees & Timelines
Quality
Assurance
Pharmacy Site Visits
Professional Development
MedSTEP NL
Frequently-Asked Questions About Professional Development
Pharmacy
Practice
Legislation
Standards, Guidelines, Policies & Positions
Provincial Drug Schedules
Pharmacy Practice Resources
Frequently Asked Questions About Pharmacy Practice
News
& Advisories
NLPB News
Health Canada & ISMP Advisories
Registrant
Login
Home
About The Board
- Board Members
- Committees
- Contact Us
For The Public
- Find a Registered Pharmacy Professional or Licensed Pharmacy
- Newfoundland and Labrador Pharmacy Museum
Complaints & Discipline
- Complaints & Discipline Overview
- Hearing Details
- Adjudication Tribunal Decisions
Registration & Licensing
- Registration Requirements
- Registration Exam
- Register as a Pharmacist
- Register as a Pharmacy Technician
- Register as a Pharmacy Student or Intern
- Annual Registration Renewal
- Leave and Re-registration
- Authorization for Registrants
- License a Pharmacy
- Authorization for Pharmacies
- Fees & Timelines
Quality Assurance
- Pharmacy Site Visits
- Professional Development
- MedSTEP NL
- Frequently-Asked Questions about Professional Development
Pharmacy Practice
- Legislation
- Standards, Guidelines, Policies & Positions
- Provincial Drug Schedules
- Pharmacy Practice Resources
- Frequently Asked Questions About Pharmacy Practice
News & Advisories
- NLPB News
- Health Canada & ISMP Advisories
Contact Us
Disclaimer
Site Map
%3$s
‘, ‘walker’ => new select_menu_walker() )); ?>
ZEJULA (niraparib) – Update on the Maintenance Treatment in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in the Second or Later Line Setting
February 16th, 2023
Site Search
©2023 Newfoundland & Labrador Pharmacy Board
